Get started
Author

Thomas Kuehr

Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
2022 · Margaret A. Tempero, Uwe Pelzer, et al. · Journal of Clinical Oncology · 146
PDF
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial
2019 · Kathleen M Mullane, Vicki A Morrison, et al. · The Lancet Infectious Diseases · 37
Immunogenetic analysis of spontaneous autoimmune thyroiditis of obese strain chickens
1989 · Guido Kroemer, Nikolaus Neu, et al. · Clinical Immunology and Immunopathology · 30
Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study
2014 · H. Ludwig, E. Rauch, et al. · Haematologica · 29
PDF
Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in Europe
2022 · Evangelos Terpos, Renato Zambello, et al. · Cancers · 12
PDF
Real‐world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel
2022 · Xavier Leleu, Eirini Katodritou, et al. · eJHaem · 11
PDF
A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha‐2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)—AGMT_CML 1
2020 · Sonja Heibl, Veronika Buxhofer‐Ausch, et al. · Hematological Oncology · 11
Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer
2004 · Thomas Kuehr, Paul Ruff, et al. · BMC Cancer · 9
PDF
A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) – AGMT_CMML-1
2017 · Sonja Burgstaller, Reinhard Stauder, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 8
Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma
2019 · Andreas Seeber, Lukas Weiss, et al. · Wiener klinische Wochenschrift · 5
A Phase I Study of Lenalidomide in Patients with Chronic Myelomonocytic Leukaemia (CMML) – AGMT_CMML 1
2014 · Sonja Burgstaller, Richard Greil, et al. · Blood · 1
Lenalidomide and Dexamethasone for Acute Light Chain-Induced Renal Failure: Final Results of a Phase II Study
2014 · Heinz Ludwig, Elisabeth Rauch, et al. · Blood · 1
P-220: Use of Carfilzomib regimens in patients with Multiple Myeloma refractory to CD38 antibodies: a subgroup analysis from a prospective observational study
2021 · Evangelos Terpos, Jo Caers, et al. · Clinical Lymphoma Myeloma & Leukemia
Author response for "A Phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha 2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia not achieving a deep molecular response (MR 4.5) – AGMT_CML 1"
2020 · Sonja Heibl, Veronika Buxhofer‐Ausch, et al.
Real-World multicenter Austrian analysis of the safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer
2018 · G. Steger, E. Petru, et al. · European Journal of Cancer
CPT-11 and 5 fluorouracil/folinic acid (5-FU/FA) mayo clinic regimen in advanced colorectal cancer (CRC) as front line therapy: a phase I/II study
2001 · T. Kuehr, P. Ruff, et al. · European Journal of Cancer
Works count: 17
Citation count: 300
H-index: 8
I10-index: 7
Year
Topic
Type